Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-21-050759

President & CEO bought 867 shares at $3.62 ($3,139)

From the SEC's structured data for this filing

Trades in this filing

USMAN NASSIM · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-08-09 Purchase : show line 1 in the form +867 $3.62 $3,139 18,041 D
Open-market purchases · 867 sh · avg $3.62 · $3,139
Loading xslF345X03/doc4.xml…